ASML Fell 8% on China Chip News That Doesn't Touch Its Real Moat
On Monday, a Shanghai-based, state-backed chipmaking tool company said it had started producing its own immersion DUV lithography machines. Within hours, ASML had shed more than 8% of its market cap — roughly $44 billion gone in a single session. If you only read the headline, you'd think ASML's business just took a direct hit. Look at the actual numbers behind the story, and the reaction looks like a classic case of the market pricing in a threat that barely touches the company's core business.
What Actually Happened in China
The domestic tool is planned to ship in tiny volumes — five units in 2026, scaling to about 20 in 2027 — to SMIC, Hua Hong, and ChangXin Memory Technologies (CXMT) for line validation, not full production runs. Industry assessments say the machine still lags ASML by roughly a full generation on throughput, overlay accuracy, and long-term reliability. Put those 2026-2027 shipment plans against ASML's own numbers: those Chinese units represent just 3.8% of ASML's targeted 2026 immersion-DUV capacity of about 130 systems, and 11.8% of its projected 2027 capacity of roughly 169 systems. That's the entire basis for an $44 billion single-day repricing.
This is the same China-chip-shock story that hammered Kospi's Worst Day Ever and drove the panic I covered in Kospi Triggers Circuit Breaker as Chip Shock Wipes Out Billions. But Samsung and SK Hynix actually compete with CXMT in memory chips — ASML doesn't. ASML sells the equipment; it's the arms dealer, not a combatant.
DUV Isn't the Business You Should Be Worried About
Here's the detail that got buried in Monday's selloff: EUV lithography machines — the ones actually needed to make cutting-edge logic chips for Nvidia, Apple, and AMD's most advanced products — have never shipped to China at all, under any administration's export rules. ASML remains the only company on the planet that makes them, full stop, after Nikon and Canon exited the segment over a decade ago. The Shanghai tool is a DUV machine, an older-generation technology ASML was already being forced to wind down in China because of existing US export controls. China's DUV news doesn't erode ASML's moat — it's building a domestic substitute for a product category ASML's already losing access to for policy reasons, not technology ones.
China made up about 33% of ASML's 2025 revenue. That's expected to fall to roughly 20% in 2026 — and that decline was already baked into ASML's guidance before this week's headline. The lost DUV revenue is being replaced by higher-margin EUV demand from AI customers in Taiwan, Korea, and the US, which is exactly why ASML raised its 2026 revenue guidance to €43-45 billion even as the China business shrinks.
The Real Risk Isn't the One Everyone's Talking About
If you want to find the genuine threat to ASML's China business, it isn't a homegrown DUV tool that's a generation behind — it's Washington. The proposed MATCH Act, introduced in April 2026, would go further than any prior restriction by banning ASML from servicing DUV systems it's already installed in China. Analysts estimate 15-20% of ASML's long-term revenue could be at risk if that bill passes in its current form. That's a policy risk with a real dollar figure attached to it, and it got a fraction of the market's attention this week compared to a five-machine pilot program from a company that's still catching up on 2010s-era tooling.
- Chinese DUV units shipping 2026-2027: ~25 total, vs. ASML's ~300 systems planned across both years
- ASML's China revenue share: falling from 33% (2025) to ~20% (2026), already guided for
- EUV exposure to Chinese domestic competition: zero — EUV has never shipped to China
- MATCH Act revenue-at-risk estimate: 15-20% of long-term revenue if passed
Where This Could Go Wrong for Me
I'm not dismissing the China lithography story entirely. Technology gaps close faster than skeptics expect — memory chips are exactly the category where CXMT has already surprised the market once, a run I broke down in China's CXMT Surges 470% on Debut. If Chinese DUV tools hit "good enough" quality for mature-node production faster than the one-generation gap suggests, ASML's non-EUV business erodes faster than guidance assumes. And if the MATCH Act passes with the service ban intact, that 15-20% revenue-at-risk figure becomes real cash flow, not a hypothetical. Neither of those is priced at zero — they're just not what moved the stock 8% on Monday.
The Takeaway
The headline-driven selloff conflated two separate things: a marginal, several-year-out challenge to ASML's already-shrinking legacy DUV business in China, and a genuine, near-term legislative risk to its service revenue that barely got mentioned. If you're tracking ASML, the number to watch isn't how many DUV units Shanghai ships next year — it's whether the MATCH Act advances in Congress. That's the catalyst with a real, quantified revenue number attached to it, and it's the one nobody was pricing in on the day the stock actually dropped.
This is not financial advice — always do your own research before making investment decisions.
댓글
댓글 쓰기